Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Mouse models of lupus: what they tell us and what they don't.

Richard ML, Gilkeson G.

Lupus Sci Med. 2018 Jan 21;5(1):e000199. doi: 10.1136/lupus-2016-000199. eCollection 2018.

2.

Pathological significance and regulatory mechanism of lymphotoxin β receptor overexpression in T cells of patients with systemic lupus erythematosus.

Yin C, Cai XB, Wang HJ, Gu BJ, Yang XF, Zhang R, Ji XH.

J Biomed Res. 2017 Sep 30. doi: 10.7555/JBR.27.20130046. [Epub ahead of print]

3.

IL-36 Signaling Facilitates Activation of the NLRP3 Inflammasome and IL-23/IL-17 Axis in Renal Inflammation and Fibrosis.

Chi HH, Hua KF, Lin YC, Chu CL, Hsieh CY, Hsu YJ, Ka SM, Tsai YL, Liu FC, Chen A.

J Am Soc Nephrol. 2017 Jul;28(7):2022-2037. doi: 10.1681/ASN.2016080840. Epub 2017 Feb 8.

PMID:
28179433
4.

The Debate about Dendritic Cells and Macrophages in the Kidney.

Gottschalk C, Kurts C.

Front Immunol. 2015 Sep 1;6:435. doi: 10.3389/fimmu.2015.00435. eCollection 2015. Review.

5.

Dendritic cells and macrophages in the kidney: a spectrum of good and evil.

Rogers NM, Ferenbach DA, Isenberg JS, Thomson AW, Hughes J.

Nat Rev Nephrol. 2014 Nov;10(11):625-43. doi: 10.1038/nrneph.2014.170. Epub 2014 Sep 30. Review.

6.

Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease.

Nackiewicz D, Dey P, Szczerba B, Mohammad S, Kaplan JL, McNamara CA, Deshmukh US, Bagavant H.

Nephron Exp Nephrol. 2014;126(3):141-7. doi: 10.1159/000362452. Epub 2014 May 16.

7.

Systemic lupus erythematosus and granulomatous lymphadenopathy.

Shrestha D, Dhakal AK, Shiva RK, Shakya A, Shah SC, Shakya H.

BMC Pediatr. 2013 Nov 5;13:179. doi: 10.1186/1471-2431-13-179.

8.

Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis.

Ge Y, Jiang C, Sung SS, Bagavant H, Dai C, Wang H, Kannapell CC, Cathro HP, Gaskin F, Fu SM.

J Exp Med. 2013 Oct 21;210(11):2387-401. doi: 10.1084/jem.20130731. Epub 2013 Oct 7.

9.

Immune and inflammatory role in renal disease.

Imig JD, Ryan MJ.

Compr Physiol. 2013 Apr;3(2):957-76. doi: 10.1002/cphy.c120028. Review.

10.

Activated CD4+ T cells target mesangial antigens and initiate glomerulonephritis.

Scindia Y, Nackiewicz D, Dey P, Szymula A, Bajwa A, Rosin DL, Bolton WK, Okusa MD, Deshmukh U, Bagavant H.

Nephron Exp Nephrol. 2012;121(1-2):e1-9. doi: 10.1159/000342368. Epub 2012 Oct 19.

11.

The Role of Hyaluronan and CD44 in the Pathogenesis of Lupus Nephritis.

Yung S, Chan TM.

Autoimmune Dis. 2012;2012:207190. doi: 10.1155/2012/207190. Epub 2012 Aug 1.

12.

The renal mononuclear phagocytic system.

Nelson PJ, Rees AJ, Griffin MD, Hughes J, Kurts C, Duffield J.

J Am Soc Nephrol. 2012 Feb;23(2):194-203. doi: 10.1681/ASN.2011070680. Epub 2011 Dec 1. Review.

13.

Lupus nephritis: current update.

Saxena R, Mahajan T, Mohan C.

Arthritis Res Ther. 2011;13(5):240. doi: 10.1186/ar3378. Epub 2011 Sep 28. Review.

14.

Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models.

Pathak S, Mohan C.

Arthritis Res Ther. 2011;13(5):241. doi: 10.1186/ar3465. Epub 2011 Sep 30. Review.

15.

Deficiency of a transcriptional regulator, inhibitor of differentiation 3, induces glomerulonephritis in apolipoprotein E-deficient mice: a model linking hyperlipidemia and renal disease.

Bagavant H, Scindia Y, Nackiewicz D, Nandula SR, Doran A, Cutchins A, Oldham S, Deshmukh U, McNamara C.

Am J Pathol. 2011 Aug;179(2):651-60. doi: 10.1016/j.ajpath.2011.04.029. Epub 2011 Jun 14.

16.

The histone peptide H4 71-94 alone is more effective than a cocktail of peptide epitopes in controlling lupus: immunoregulatory mechanisms.

Kang HK, Chiang MY, Liu M, Ecklund D, Datta SK.

J Clin Immunol. 2011 Jun;31(3):379-94. doi: 10.1007/s10875-010-9504-4. Epub 2011 Feb 3.

17.

Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice.

Bagavant H, Kalantarinia K, Scindia Y, Deshmukh U.

Am J Kidney Dis. 2011 Mar;57(3):498-507. doi: 10.1053/j.ajkd.2010.10.052. Epub 2011 Jan 15. Review.

18.

Mesangial pathology in glomerular disease: targets for therapeutic intervention.

Scindia YM, Deshmukh US, Bagavant H.

Adv Drug Deliv Rev. 2010 Nov 30;62(14):1337-43. doi: 10.1016/j.addr.2010.08.011. Epub 2010 Sep 7. Review.

19.

Kidney dendritic cells in acute and chronic renal disease.

Hochheiser K, Tittel A, Kurts C.

Int J Exp Pathol. 2011 Jun;92(3):193-201. doi: 10.1111/j.1365-2613.2010.00728.x. Epub 2010 Jul 30. Review.

20.

Supplemental Content

Support Center